Qlaris Bio

Qlaris Bio is a clinical-stage biotechnology company focused on developing first-in-class therapies for ophthalmic diseases, with a mission to preserve vision and prevent blindness. Its lead candidate, QLS-111, uses a novel mechanism of action to lower intraocular pressure by targeting the distal outflow pathway, and is being evaluated for primary open-angle glaucoma, ocular hypertension, and elevated IOP associated with conditions such as Sturge-Weber Syndrome. The company was surfaced as a portfolio company of Canaan Partners and added to the API Evangelist network. As a clinical-stage drug developer, Qlaris Bio publishes a corporate website but no public developer, API, or product integration surface.

Qlaris Bio is profiled on the APIs.io network. Tagged areas include Company, Biotechnology, Pharmaceuticals, Ophthalmology, and Glaucoma.

Qlaris Bio’s developer surface includes engineering blog and 6 more developer resources.

🌐 Visit website 📡 Source on GitHub
14.3/100 minimal ▬ flat Agent 0/100 human only Full breakdown ↓
scored 2026-07-27 · rubric v0.5
0 APIs
CompanyBiotechnologyPharmaceuticalsOphthalmologyGlaucomaClinical StageLife SciencesHealthcare

Kin Score

Kin Score Kin Score How this is scored →
scored 2026-07-27 · rubric v0.5
Composite quality — 14.3/100 · minimal
Contract Quality 0.0 / 25
Developer Ergonomics 0.4 / 20
Commercial Clarity 4.2 / 20
Operational Transparency 0.0 / 13
Governance 0.0 / 12
Discoverability 6.8 / 10
Agent readiness — 0/100 · human only
Machine-Readable Contract 0 / 18
Agentic Access Contract 0 / 15
MCP Server 0 / 12
Machine-Readable Auth 0 / 10
Idempotency 0 / 9
Stable Error Semantics 0 / 8
Request/Response Examples 0 / 7
Rate-Limit Signaling 0 / 7
Typed Event Surface 0 / 6
Agent Skills 0 / 5
Well-Known Catalog 0 / 4
Consent & Bot Identity 0 / 3
Improve this rating by publishing the missing artifacts — every area above can be raised, and the full rubric is at apis.io/rating/. This rating is computed from github.com/api-evangelist/qlaris-bio: open an issue to ask a question, or submit a pull request to add artifacts. Want it done for you? Prioritized profiling — $2,500 →

Security Posture 1

Authentication, domain security, vulnerability disclosure, and trust-center signals.

Qlaris Bio Domain Security

TLSv1.3 · DMARC

SECURITY

Resources

Access & Security 1

Authentication, authorization, and security posture

DomainSecurity
DomainSecurity

Commercial 2

Pricing, plans, and the legal terms of use

PrivacyPolicy
PrivacyPolicy
 TermsOfService
TermsOfService

Company 4

The organization behind the API

Website
Website
 About
About
 Blog
Blog
 LinkedIn
LinkedIn

Source (apis.yml)

apis.yml Raw ↑ 
aid: qlaris-bio
name: Qlaris Bio
description: Qlaris Bio is a clinical-stage biotechnology company focused on developing first-in-class therapies for ophthalmic
  diseases, with a mission to preserve vision and prevent blindness. Its lead candidate, QLS-111, uses a novel mechanism of
  action to lower intraocular pressure by targeting the distal outflow pathway, and is being evaluated for primary open-angle
  glaucoma, ocular hypertension, and elevated IOP associated with conditions such as Sturge-Weber Syndrome. The company was
  surfaced as a portfolio company of Canaan Partners and added to the API Evangelist network. As a clinical-stage drug developer,
  Qlaris Bio publishes a corporate website but no public developer, API, or product integration surface.
url: https://raw.githubusercontent.com/api-evangelist/qlaris-bio/refs/heads/main/apis.yml
x-type: company
x-source: vc-portfolio
x-backed-by:
- canaan-partners
x-tier: stub
x-tier-reason: portfolio-lead
accessModel:
  pricing: unknown
  onboarding: unknown
  trial: false
  try_now: false
  public: false
  label: Unknown
  confidence: low
  source: []
  generated: '2026-07-22'
  method: derived
specificationVersion: '0.20'
created: '2026-07-17'
modified: '2026-07-20'
tags:
- Company
- Biotechnology
- Pharmaceuticals
- Ophthalmology
- Glaucoma
- Clinical Stage
- Life Sciences
- Healthcare
image: https://qlaris.bio/
apis: []
common:
- type: Website
  url: https://qlaris.bio/
- type: About
  url: https://qlaris.bio/about-us/
- type: Blog
  url: https://qlaris.bio/news-events/
- type: PrivacyPolicy
  url: https://qlaris.bio/privacy-policy/
- type: TermsOfService
  url: https://qlaris.bio/terms-of-use/
- type: LinkedIn
  url: https://www.linkedin.com/company/qlaris-bio-inc/
- type: DomainSecurity
  url: security/qlaris-bio-domain-security.yml
maintainers:
- FN: Kin Lane
  email: kin@apievangelist.com
- FN: APIs.json
  email: info@apis.io
x-enrichment:
  date: '2026-07-20'
  status: minimal
  artifacts_added: 1
  pass: local-v1